The ALS Recovery Fund, a steadfast ally in the fight against amyotrophic lateral sclerosis, commonly known as Lou Gehrig’s disease, has pledged another $1 million to the Department of Neurology for its continued ALS research and patient support. Partner Kevin Packman, Chairman and CEO of the ALS Recovery Fund, learned of the devastation of ALS firsthand when his father was diagnosed with the deadly disease. “This gift will permit us to continue to enhance and expand the care provided to ALS patients in South Florida,” Mr. Packman said.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.